Approval · Notice of Compliance 731 · 2002
TAMIFLU: Notice of Compliance 731
Issued March 11, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 731
- Date
- March 11, 2002
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form and indication - powder for oral susupension to be used in the treatment of pediatric patients one year and older
- Therapeutic class
- Antiviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TAMIFLU | 02245549 | Cancelled Post Market |
Medicinal ingredients
- OSELTAMIVIR PHOSPHATE 12 MG per ML